5-hydroxytryptamine 2 receptors | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

79,809 results for “5-hydroxytryptamine 2 receptors”

Trials

View all 50720 →

ITMCTR2100004950

Effect of ear acupoint sticking therapy on gastrin and 5-hydroxytryptamine in patients after total knee arthroplasty

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing

28 participants · First posted Jan 13, 2017

Not yet recruiting

Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.

100 participants · First posted Jan 1, 2025

Drugs

View all 9420 →

Dipropyl-4-hydroxytryptamine

C₁₆H₂₄N₂O

DA/5-HT stabilizers (Adamed)

Aom-0811

Organizations

View all 2386 →

Center 5

United States

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

News

View all 17283 →

Harmony Biosciences to Present Phase 3 EPX-100 Data for Dravet Syndrome at AES Annual Meeting

Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies

Insulet's Omnipod 5 Demonstrates Significant HbA1c Reduction in Type 2 Diabetes Study

Page 1 of 7981